Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer
- DOI
- 10.1016/j.tranon.2024.102025
- Published
- 2024-08
- Container
- Translational Oncology
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.tranon.2024.102025,
title = {Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer},
author = {Subhasree Rajaram and Naoise C. Synnott and John Crown and Stephen F. Madden and Michael J. Duffy},
year = {2024},
journal = {Translational Oncology},
doi = {10.1016/j.tranon.2024.102025},
url = {https://doi.org/10.1016/j.tranon.2024.102025}
}RIS
TY - JOUR TI - Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer AU - Subhasree Rajaram AU - Naoise C. Synnott AU - John Crown AU - Stephen F. Madden AU - Michael J. Duffy PY - 2024 JO - Translational Oncology DO - 10.1016/j.tranon.2024.102025 UR - https://doi.org/10.1016/j.tranon.2024.102025 ER -
APA
Rajaram, S., Synnott, N. C., Crown, J., Madden, S. F., & Duffy, M. J. (2024). Targeting mutant p53 with arsenic trioxide: A preclinical study focusing on triple negative breast cancer. Translational Oncology. https://doi.org/10.1016/j.tranon.2024.102025
Source records
- crossref · retrieved 2026-09-26T08:31:55.392Z